02 Jul AstraZeneca Pharma India shares rise over 2% after CDSCO clears Imfinzi for new cancer use
[ad_1] Shares of AstraZeneca Pharma India rose over 2% to Rs 9100 on BSE in Wednesday's trade after the company received regulatory approval for a new use of its cancer therapy Imfinzi.On Tuesday, AstraZeneca Pharma India announced that it has received clearance from the Central...